PhD opportunities


A collaborative research training programme for medical doctors

Call open

Deadline for applications: 21 March 2018

IRB Barcelona International PhD Fellowships 2018

Call closed

Deadline for applications: 14 January 2018 at 15:00h (CET)

PhD Thesis Defences

PhD Thesis Defended

Stay tuned for upcoming PhD Thesis Defences.

For a complete list of past defences, please see PhD Theses Defended.



Postdoctoral Fellow

“From our study in Drosophila flies we can deduce that it would be particularly interesting to address vertebrates and analyse the participation of p53 in diabetes and obesity”

More on this news here

Postdoctoral Fellow

«Our study highlights the complexity of p38 functions, both in cancer and in the maintenance of normal tissues. It shows why an inhibitor of this molecule could effectively have undesirable side effects. But these do not exclude it from being a target against cancer.»

More on this news here.

PhD Student

«I discovered that the bantam molecule drives the transition from larva to pupa, the phase analogous to human adolescence.»

More info about this news here.

IRB Barcelona Alumni member

«We suspected that CPEB1, a protein involved in regulating mRNA translation in the cytoplasm, might also be active in the nucleus and play a role in controlling pre-mRNA processing. We discovered that it affects the alternative generation in the mature mRNA of the 3'-UTR, regions where most of the elements regulating translation in time and space are located.»

More info about this news here.

KEY Publications by our PhD students

Silva J, Aivio S, Knobel PA, Bailey LJ, Casali A, Vinaixa M, Garcia-Cao I, Coyaud É, Jourdain AA, Pérez-Ferreros P, Rojas AM, Antolin-Fontes A, Samino-Gené S, Raught B, González-Reyes A, Ribas de Pouplana L, Doherty AJ, Yanes O and Stracker TH.
Nat Cell Biol (2), 162 - 174 (2018)
Solanas G, Peixoto FO, Perdiguero E, Jardí M, Ruiz-Bonilla V, Datta D, Symeonidi A, Castellanos A, Welz PS, Caballero JM, Sassone-Corsi P, Muñoz-Cánoves P and Benitah SA.
Cell (4), 678 - 692.e2 (2017)
Pascual G, Avgustinova A, Mejetta S, Martín M, Castellanos A, Attolini CS, Berenguer A, Prats N, Toll A, Hueto JA, Bescós C, Di Croce L and Benitah SA.
Nature (7635), 41 - 45 (2017)
Bayona-Feliu A, Casas-Lamesa A, Reina O, Bernués J and Azorín F.
Nat Commun (1), 283 - (2017)
Maillo C, Martín J, Sebastián D, Hernández-Alvarez M, García-Rocha M, Reina O, Zorzano A, Fernandez M and Méndez R.
Nat Cell Biol (2), 94 - 105 (2017)
Cortina C, Turon G, Stork D, Hernando-Momblona X, Sevillano M, Aguilera M, Tosi S, Merlos-Suárez A, Stephan-Otto Attolini C, Sancho E and Batlle E.
EMBO Mol Med (), - (2017)

Further information

D’acord amb l’article 9 de la convocatòria dels ajuts FI- 2018, RESOLUCIÓ EMC/2199/2017, de 14 de setembre, es publica la priorització dels ajuts FI 2018.
Alhora s’obre un període d’al·legacions que finalitzarà el 11 de Desembre de 2017.


<p>Julien Colombelli, Core Facility Manager of the Advanced Digital Microscopy Laboratory at IRB Barcelona.</p>
28 Feb 2018

For the second year in a row, IRB Barcelona, in collaboration with BIST (Barcelona Institute of Science and Technology), will participa

<p>Age-related hearing loss involves several environmental factors and genes. Image: CIBERER</p>
23 Feb 2018

Age-related hearing loss is a multifactor-origin disease which affects almost one out of three people aged between 65 and 74.

<p>The overexpression of the gene Serpent in the Drosophila wing causes permanent overgrowth and it is sufficient to promote tumour development. Image: Kyra Campbell, IRB Barcelona</p>
19 Feb 2018

In cancer research, there has been a tendency to differentiate between the genes responsible for tumour development and those that give rise to metastasis and to study these processes separately si

<p>The image shows a metastatic colon tumour infiltrated by the immune system (brown) after combined treatment with the TGF-beta inhibitor and immunotherapy.  (Author: Daniele Tauriello, IRB Barcelona)</p>
14 Feb 2018

In a short space of time, immunotherapy, that is to say therapies based on stimulating the immune system against cancer cells, has become a powerful approach to treat cancers such as melanoma and l


Clara Caminal
Section Head of Academic & International Scientific Affairs Office
Tel: +34 93 40 34880